OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 76 filers reported holding OPHTHOTECH CORP in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $38,000 | +31.0% | 13,500 | +19.5% | 0.08% | -69.5% |
| Q2 2017 | $29,000 | -94.8% | 11,300 | -18.1% | 0.28% | +461.2% |
| Q3 2015 | $559,000 | -54.7% | 13,800 | -41.8% | 0.05% | -52.9% |
| Q2 2015 | $1,234,000 | +201.7% | 23,700 | +169.3% | 0.10% | +197.1% |
| Q1 2015 | $409,000 | – | 8,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |